NCT00109083View on ClinicalTrials.gov

A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine

PHASE2CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions

Migraine Headaches

Interventions

DRUG

RWJ-333369

Trial Locations (25)

Unknown

Northport

Phoenix

Little Rock

Berkeley

Golden

Miami

St. Petersburg

Chicago

Baton Rouge

Brockton

Springfield

Chaska

Springfield

Greensboro

Bismarck

Cincinnati

Mogadore

Nashville

Austin

Houston

Lake Jackson

Richardson

Alexandria

Olympia

Middleton

All Listed Sponsors

lead

SK Life Science, Inc.

INDUSTRY

NCT00109083 - A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine | Biotech Hunter | Biotech Hunter